Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

被引:152
作者
Biftu, Tesfaye [1 ]
Sinha-Roy, Ranabir [2 ]
Chen, Ping [1 ]
Qian, Xiaoxia [1 ]
Feng, Dennis [1 ]
Kuethe, Jeffrey T. [1 ]
Scapin, Giovanna [1 ]
Gao, Ying Duo [1 ]
Tan, Youwei [1 ]
Krueger, Davida [5 ]
Bak, Annette [5 ]
Eiermann, George [3 ]
He, Jiafang [1 ]
Cox, Jason [1 ]
Hicks, Jacqueline [1 ]
Lyons, Kathy [4 ]
He, Huaibing [4 ]
Salituro, Gino [4 ]
Tong, Sharon [4 ]
Patel, Sangita [1 ]
Doss, George [1 ]
Petrov, Aleksandr [3 ]
Wu, Joseph [2 ]
Xu, Shiyao Sherrie [4 ]
Sewall, Charles [6 ]
Zhang, Xiaoping [2 ]
Zhang, Bei [2 ]
Thornberry, Nancy A. [2 ]
Weber, Ann E. [1 ]
机构
[1] Merck & Co Inc, Dept Discovery Chem, Whitehouse Stn, NJ 08889 USA
[2] Merck & Co Inc, Dept Metab Disorders, Whitehouse Stn, NJ 08889 USA
[3] Merck & Co Inc, Dept Pharmacol, Whitehouse Stn, NJ 08889 USA
[4] Merck & Co Inc, Dept Drug Metab, Whitehouse Stn, NJ 08889 USA
[5] Merck & Co Inc, Basic Pharmaceut Sci, Whitehouse Stn, NJ 08889 USA
[6] Merck & Co Inc, Dept Safety Assessment & Anim Resources, Whitehouse Stn, NJ 08889 USA
关键词
DIPEPTIDYL-PEPTIDASE-IV; RATIONAL DESIGN; IDENTIFICATION; HOMOLOG; CLONING; POTENT;
D O I
10.1021/jm401992e
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
In our effort to discover DPP-4 inhibitors with added benefits over currently commercially available DPP-4 inhibitors, MK-3102 (omarigliptin), was identified as a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor with an excellent pharmacokinetic profile amenable for once-weekly human dosing and selected as a clinical development candidate. This manuscript summarizes the mechanism of action, scientific rationale, medicinal chemistry, pharmacokinetic properties, and human efficacy data for omarigliptin, which is currently in phase 3 clinical development.
引用
收藏
页码:3205 / 3212
页数:8
相关论文
共 20 条
[1]
Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8 [J].
Abbott, CA ;
Yu, DMT ;
Woollatt, E ;
Sutherland, GR ;
McCaughan, GW ;
Gorrell, MD .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6140-6150
[2]
[Anonymous], IDF DIAB ATL
[3]
Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (23) [J].
Biftu, Tesfaye ;
Qian, Xiaoxia ;
Chen, Ping ;
Feng, Dennis ;
Scapin, Giovanna ;
Gao, Ying-Duo ;
Cox, Jason ;
Roy, Ranabir Sinha ;
Eiermann, George ;
He, Huabing ;
Lyons, Kathy ;
Salituro, Gino ;
Patel, Sangita ;
Petrov, Alexander ;
Xu, Feng ;
Xu, Shiyao Sherrie ;
Zhang, Bei ;
Caldwell, Charles ;
Wu, Joseph K. ;
Lyons, Kathy ;
Weber, Ann E. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) :5361-5366
[4]
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin [J].
Biftua, Tesfaye ;
Scapin, Giovanna ;
Singh, Suresh ;
Feng, Dennis ;
Becker, Joe W. ;
Eiermann, George ;
He, Hualbing ;
Lyons, Kathy ;
Patel, Sangita ;
Petrov, Aleksandr ;
Sinha-Roy, Ranabir ;
Zhang, Bei ;
Wu, Joseph ;
Zhang, Xiaoping ;
Doss, George A. ;
Thornberry, Nancy A. ;
Weber, Ann E. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) :3384-3387
[5]
Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1 [J].
Brubaker, Patricia L. .
ENDOCRINOLOGY, 2010, 151 (05) :1984-1989
[6]
Purification, identification and characterisation of seprase from bovine serum [J].
Collins, PJ ;
McMahon, G ;
O'Brien, P ;
O'Connor, B .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (11) :2320-2333
[7]
Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance [J].
Conarello, SL ;
Li, ZH ;
Ronan, J ;
Roy, RS ;
Zhu, L ;
Jiang, GQ ;
Liu, F ;
Woods, J ;
Zycband, E ;
Moller, DE ;
Thornberry, NA ;
Zhang, BB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6825-6830
[8]
A systematic review of adherence with medications for diabetes [J].
Cramer, JA .
DIABETES CARE, 2004, 27 (05) :1218-1224
[9]
Evans D Michael, 2002, IDrugs, V5, P577
[10]
Gantz I., 2012, 48 ANN M EUR ASS STU